SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,335 | +5.8% | 176 | 0.0% | 0.00% | – |
Q2 2023 | $20,156 | -55.3% | 176 | -46.2% | 0.00% | -100.0% |
Q1 2023 | $45,070 | +107209.5% | 327 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $42 | -99.9% | 327 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $36,000 | +24.1% | 327 | -13.3% | 0.00% | – |
Q2 2022 | $29,000 | -50.8% | 377 | -50.1% | 0.00% | -100.0% |
Q1 2022 | $59,000 | -14.5% | 756 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $69,000 | – | 756 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |